Clinical Trials List
2020-07-01 - 2027-07-31
Phase I
Not yet recruiting1
Recruiting5
ICD-10C18.9
Malignant neoplasm of colon, unspecified
ICD-10C7A.029
Malignant carcinoid tumor of the large intestine, unspecified portion
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.9
Malignant neoplasm of colon, unspecified
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- YEN-SHEN LU 未分科
- 陳怡君 未分科
- Ann-Lii Cheng 未分科
- YU-YUN SHAO 未分科
- 廖斌志 無
- Wei-Wu Chen 未分科
- FU-JEN HSUEH 未分科
- Ying-Chun Shen 未分科
- HUAI-CHENG HUANG 無
- SHIH-HUNG YANG 無
- 張端瑩 未分科
- Yu-Chieh Tsai 未分科
- Chiun Hsu 未分科
- TSUNG-HAO LIU 無
- 陳怡君 無
- 林季宏 未分科
- SHIH-HUNG YANG 未分科
- Chih-Hung Hsu 未分科
- 呂理駿 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yao-Chung Wu 無
- Yu-Min Liao 無
- Liang-Chih Liu 無
- Ching Yun Hsieh 未分科
- Ching-Chan Lin 無
- Li-Yuan Bai 無
- Ming-Yu Lien 未分科
- Ming-Hung Tsai 無
- Su-Peng Yeh 無
- Chen-Teng Wu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳佳哲
- Tai-Jan Chiu
- 陳彥豪 Division of Hematology & Oncology
- 林偉雄
- 陳彥仰
- 林昶廷
- 郭明濬
- 劉建廷 Division of Hematology & Oncology
- Shau-Hsuan Li
- 黃詩喻 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 余紹銘 Division of Hematology & Oncology
- PO-HUNG LIN
- See-Tong Pang Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- 沈鼎文 Division of Radiology
- 張境夫 Division of Hematology & Oncology
- Chun-Te Wu Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
362 participants